Diseases and Specialised Medicine
The Academic Directorate of Communicable Diseases and Specialised Medicine comprises of five specialities:
Research and Innovation Strategy 2023-2026
RI Strategy Copy (sth.nhs.uk)
The modulation of macrophage apoptosis during Streptococcus pneumoniae infection by HIV-1
Key Contacts
|
Name
|
Role |
|---|---|
| Dr Nicholas Morley | Clinical Director - Haematology |
|
Dr Benjamin Stone
|
Clinical Director - Communicable Diseases
|
| Prof John Snowden | Research Lead - CDSM |
| Dr Jack Goddard | Research Lead - Haematology-Oncology |
| Dr Matthew Sims | Research Lead - Haematology |
| Dr Claire Dewsnap | Research Lead - Sexual Health and GUM |
| Dr Joby Cole | Research Lead - Infectious Diseases |
| Dr Sarah Denness | Research Lead - Immunology |
| Dr Sura Sahib | Research Lead - Dermatology |
| Dr Eva Zincone eva.zincone@nhs.net | Directorate Research Coordinator |
| Melanie Fox melanie.fox6@nhs.net | Industry Research Coordinator |
| Adam Smith adam.smith78@nhs.net | CRIO Research Coordinator |
| Grace Cole grace.cole1@nhs.net | CRIO Research Coordinator (Haemato-Oncology) |
| Jekatarina Kudina jekatarina.kudina@nhs.net | CDSM Research Administrator |
| Sth.CDSMresearch@nhs.net | Please use this email for general enquiries |
Communicable Diseases
The Communicable Diseases team focuses on the prevention and treatment of infectious diseases through behavioural modification, vaccination and preventive treatment. Since all sectors of society are at risk of infections these approaches impact the lives of all society. Moreover since many of the problems we tackle, such as HIV, hepatitis, influenza, enteric fever and pneumonia have global reach our research is relevant not just in the UK.
.png)
.png)
Specialised Medicine
The diverse specialties encompassed in the specialised medicine team address some of the most common disorders presenting to healthcare professionals within the NHS, ranging from dermatological, immune and haematological disorders including cancer.
Haematology
- Lymphoid Team - specialising in research on all lymphoid malignancies
-
Myeloma Team - advancing studies in the field of myeloma, with interest in autologous HSCT for myeloma, multiple myeloma and myeloma transplant
- Myeloid Team - driving research in all myeloid disorders such as AML, MDS, Graft-vs-host disease.
BLOOD CANCER RESEARCH AT SHEFFIELD TEACHING HOSPITALS
.png)


- Novel non-factor haemophilia treatment
- Gene therapy in haemophilia
- Long-acting factor treatments for haemophilia
- Joint disease in haemophilia
- Genetics of rare bleeding conditions
-
Sickle cell disease
-
Haemoglobinopathies (including Thalassemia and Sickle Cell)
-
Red Cell Disorders
- Mechanisms of Haemostasis and Thrombosis
- Advances in Clotting and Bleeding Management
Our consultant Dr Ravishankar Sargur's most recent publications (updated September 2024):
-
Rejection of Fecal Immunochemical Tests Within the Lower Gastrointestinal Diagnostic Pathway: A Cohort Study. DOI:10.1177/21501319241228161
-
Evaluation of Cryoprotein Investigation Using A Digital External Quality Assurance Scheme. DOI:10.1177/00045632241239805
-
Psoriasis
-
Atopic dermatitis (Eczema)
-
Registry studies of patients receiving treatment for dermatological conditions
-
Alopecia
.png)
.png)



